Adipsic diabetes insipidus.
Kothari V, Cardona Z, Eisenberg Y.
Handb Clin Neurol. 2021;181:261-273. doi: 10.1016/B978-0-12-820683-6.00019-1.
Evaluation and treatment of hypernatremia: a practical guide for physicians.
Liamis G, Filippatos TD, Elisaf MS.
Postgrad Med. 2016;128(3):299-306. doi: 10.1080/00325481.2016.1147322. Epub 2016 Feb 23.
Ongoing peer-review issues.
Sutherland T.
Intern Med J. 2020 May;50(5):646. doi: 10.1111/imj.14832.
Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial.
Atila C, Holze F, Murugesu R, Rommers N, Hutter N, Varghese N, Sailer CO, Eckert A, Heinrichs M, Liechti ME, Christ-Crain M.
Lancet Diabetes Endocrinol. 2023 Jul;11(7):454-464. doi: 10.1016/S2213-8587(23)00120-1. Epub 2023 May 13.
[Hormonal dysnatremia].
Karaca P, Desailloud R.
Ann Endocrinol (Paris). 2013 Oct;74 Suppl 1:S42-51. doi: 10.1016/S0003-4266(13)70020-9.
Hyponatremia and hypernatremia.
Fried LF, Palevsky PM.
Med Clin North Am. 1997 May;81(3):585-609. doi: 10.1016/s0025-7125(05)70535-6.
Diuretic update.
Williamson HE.
Iowa Med. 1985 Aug;75(8):364-6, 368.
Renal aquaporins: an overview.
Nielsen S.
BJU Int. 2002 Dec;90 Suppl 3:1-6. doi: 10.1046/j.1464-410x.90.s3.1.x.
Iatrogenic endocrine complications of lithium therapy.
Vantyghem MC.
Ann Endocrinol (Paris). 2023 May;84(3):391-397. doi: 10.1016/j.ando.2023.03.004. Epub 2023 Mar 22.
Diabetes insipidus. Current treatment recommendations.
Seckl JR, Dunger DB.
Drugs. 1992 Aug;44(2):216-24. doi: 10.2165/00003495-199244020-00006.
